Symbols / BME Stock $39.12 -1.24% BlackRock Health Sciences Trust

Financial Services • Asset Management • United States • NYQ
BME (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Financial Services
Industry Asset Management
CEO —
Exch · Country NYQ · United States
Market Cap 505.59M
Enterprise Value 506.48M
Income 76.97M
Sales 7.74M
FCF (ttm) -1.96M
Book/sh 43.97
Cash/sh 548.00
Employees —
Insider 10d —
IPO Mar 29, 2005
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 53.13%
P/E 6.61
Forward P/E —
PEG —
P/S 65.36
P/B 0.89
P/C —
EV/EBITDA —
EV/Sales 65.47
Quick Ratio 0.23
Current Ratio 0.23
Debt/Eq 0.16
LT Debt/Eq —
EPS (ttm) 5.92
EPS next Y —
EPS Growth —
Revenue Growth 7.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA 0.19%
ROE 13.81%
ROIC —
Gross Margin 100.00%
Oper. Margin 20.25%
Profit Margin 9.95%
Shs Outstand 12.92M
Shs Float —
Insider Own 0.00%
Instit Own 20.95%
Short Float 0.64%
Short Ratio 1.74
Short Interest 82.20K
52W High 42.74
vs 52W High -8.47%
52W Low 34.93
vs 52W Low 12.00%
Beta 0.63
Impl. Vol. —
Rel Volume 0.95
Avg Volume 42.50K
Volume 40.33K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $39.61
Price $39.12
Change -1.24%
About

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$39.12
Latest analyst target
3. DCF / Fair value
$-2.73
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$39.12
Low
—
High
—
Mean
—
News
RSS: Latest BME news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-30 XIE H ERIN Other Executive — 11,449 — —
2026-01-30 LIU XIANG Other Executive — 389 — —
2025-01-31 XIE H ERIN Other Executive — 13,471 — —
2025-01-31 MCCLEMENTS KYLE Other Executive — 641 — —
2025-01-31 ACCETTELLA CHRISTOPHER Other Executive — 202 — —
2025-01-31 LIU XIANG Other Executive — 281 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
77.54
+222.10%
24.07
+17.94%
20.41
+178.59%
-25.97
Operating Revenue
77.54
+222.10%
24.07
+17.94%
20.41
+178.59%
-25.97
Operating Expense
0.57
-8.18%
0.62
+56.78%
0.39
-21.30%
0.50
Selling General And Administration
0.44
+23.49%
0.36
+18.89%
0.30
-17.43%
0.36
General And Administrative Expense
0.44
+23.49%
0.36
+18.89%
0.30
-17.43%
0.36
Other Operating Expenses
0.13
-51.23%
0.26
+176.58%
0.09
-31.45%
0.14
Total Unusual Items
0.00
—
—
—
Total Unusual Items Excluding Goodwill
0.00
—
—
—
Special Income Charges
0.00
—
—
—
Restructuring And Mergern Acquisition
0.00
—
—
—
Net Income
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Pretax Income
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Net Interest Income
-0.00
-11.54%
-0.00
-41.82%
-0.00
—
Interest Expense
0.00
+11.54%
0.00
+41.82%
0.00
—
Interest Income
0.00
0.00
0.00
—
Gain On Sale Of Security
28.42
-1.17%
28.76
+7.71%
26.70
+95.30%
13.67
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Net Income From Continuing Operation Net Minority Interest
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Net Income From Continuing And Discontinued Operation
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Net Income Continuous Operations
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Normalized Income
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Net Income Common Stockholders
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Diluted EPS
—
1.63
+13.19%
1.44
+168.57%
-2.10
Basic EPS
—
1.63
+13.19%
1.44
+168.57%
-2.10
Basic Average Shares
—
14.39
+3.52%
13.90
+10.28%
12.61
Diluted Average Shares
—
14.39
+3.52%
13.90
+10.28%
12.61
Diluted NI Availto Com Stockholders
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
570.14
+3.59%
550.38
-7.67%
596.10
-1.65%
606.13
Cash And Cash Equivalents
0.00
-90.94%
0.01
+1032.58%
0.00
-82.87%
0.00
Cash Financial
0.00
-90.94%
0.01
+1032.58%
0.00
-82.87%
0.00
Receivables
0.43
+5.86%
0.40
-74.96%
1.62
-31.81%
2.37
Taxes Receivable
0.00
—
—
—
Prepaid Assets
—
0.00
-100.00%
0.01
—
Investments And Advances
569.69
+3.60%
549.88
-7.49%
594.40
-1.54%
603.68
Total Liabilities Net Minority Interest
1.83
-56.76%
4.24
-46.79%
7.97
+34.31%
5.93
Payables
0.92
-18.18%
1.12
+80.93%
0.62
-30.34%
0.89
Accounts Payable
0.21
-57.02%
0.49
—
0.23
Other Payable
0.71
+12.16%
0.63
+1.57%
0.62
-5.68%
0.66
Long Term Debt And Capital Lease Obligation
—
0.15
+150.57%
0.06
+1978.29%
0.00
Stockholders Equity
568.30
+4.06%
546.14
-7.14%
588.14
-2.01%
600.20
Common Stock Equity
568.30
+4.06%
546.14
-7.14%
588.14
-2.01%
600.20
Capital Stock
357.61
-6.17%
381.13
-8.74%
417.62
-1.57%
424.30
Common Stock
357.61
-6.17%
381.13
-8.74%
417.62
-1.57%
424.30
Share Issued
12.92
-2.50%
13.26
-4.94%
13.94
+0.60%
13.86
Ordinary Shares Number
12.92
-2.50%
13.26
-4.94%
13.94
+0.60%
13.86
Retained Earnings
210.69
+27.69%
165.00
-3.23%
170.52
-3.06%
175.90
Total Equity Gross Minority Interest
568.30
+4.06%
546.14
-7.14%
588.14
-2.01%
600.20
Total Capitalization
—
768.72
+30.69%
588.20
-2.00%
600.20
Invested Capital
—
768.72
+30.69%
588.20
-2.00%
600.20
Total Debt
—
0.15
+150.57%
0.06
+1978.29%
0.00
Net Debt
—
0.08
+34.20%
0.06
+1960.00%
0.00
Net Tangible Assets
568.30
+4.06%
546.14
-7.14%
588.14
-2.01%
600.20
Tangible Book Value
568.30
+4.06%
546.14
-7.14%
588.14
-2.01%
600.20
Available For Sale Securities
4.92
-81.49%
26.55
-15.43%
31.40
+31.53%
23.87
Cash Cash Equivalents And Federal Funds Sold
0.00
-90.94%
0.01
+1032.58%
0.00
-82.87%
0.00
Derivative Product Liabilities
0.00
-100.00%
2.82
-61.20%
7.27
+68.22%
4.32
Financial Assets Designatedas Fair Value Through Profitor Loss Total
564.78
+7.92%
523.33
-7.05%
563.00
-2.90%
579.81
Investmentin Financial Assets
569.69
+3.60%
549.88
-7.49%
594.40
-1.54%
603.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
54.58
-16.69%
65.52
+104.63%
32.02
+3763.28%
-0.87
Net Income From Continuing Operations
76.97
+228.16%
23.45
+17.17%
20.02
+175.62%
-26.47
Gain Loss On Investment Securities
-23.13
-155.65%
41.56
+225.50%
12.77
-49.48%
25.27
Change In Working Capital
0.74
+45.26%
0.51
+166.54%
-0.77
-335.45%
0.33
Change In Receivables
0.59
+173.66%
0.22
+1311.67%
-0.02
+87.87%
-0.15
Change In Prepaid Assets
0.00
-100.00%
0.01
+200.00%
-0.01
0.00
Change In Accrued Expense
0.00
+62.57%
0.00
+108.23%
-0.02
-753.45%
0.00
Change In Payable
0.08
+670.57%
0.01
+126.83%
-0.04
-291.45%
-0.01
Change In Other Current Assets
0.07
+3541.82%
-0.00
+54.84%
-0.00
-133.21%
0.01
Change In Other Current Liabilities
0.00
-100.00%
0.28
+141.14%
-0.68
-245.57%
0.46
Financing Cash Flow
-54.59
+16.68%
-65.52
-104.60%
-32.02
-3754.68%
0.88
Net Issuance Payments Of Debt
0.00
+100.00%
-0.06
-205.05%
0.06
+1878.29%
0.00
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
0.00
+100.00%
-0.06
-205.05%
0.06
+1878.29%
0.00
Net Common Stock Issuance
-13.98
+52.67%
-29.53
-1077.68%
3.02
-91.01%
33.62
Common Stock Payments
-13.98
+52.67%
-29.53
0.00
0.00
Common Stock Dividend Paid
-40.61
-13.05%
-35.92
-2.34%
-35.10
-7.25%
-32.73
Cash Dividends Paid
-40.61
-13.05%
-35.92
-2.34%
-35.10
-7.25%
-32.73
Repurchase Of Capital Stock
-13.98
+52.67%
-29.53
0.00
0.00
Net Other Financing Charges
0.00
0.00
0.00
0.00
Changes In Cash
-0.01
-199.80%
0.01
+316.00%
-0.00
-220.23%
0.00
Effect Of Exchange Rate Changes
0.00
+242.86%
-0.00
+75.00%
-0.00
-187.50%
0.00
Beginning Cash Position
0.01
+1032.58%
0.00
-82.87%
0.00
+224.79%
0.00
End Cash Position
0.00
-90.94%
0.01
+1032.58%
0.00
-82.87%
0.00
Free Cash Flow
54.58
-16.69%
65.52
+104.63%
32.02
+3763.28%
-0.87
Common Stock Issuance
—
—
3.02
-91.01%
33.62
Issuance Of Capital Stock
—
—
3.02
-91.01%
33.62
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category